STRYKER CORP

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings $1.6b $1.0b $3.6b $2.1b $1.6b $2.0b $2.4b $3.2b $3.0b $3.2b
Net Income (Loss) Attributable to Parent $1.6b $1.0b $3.6b $2.1b $1.6b $2.0b $2.4b $3.2b $3.0b $3.2b
Amortization $319.0m $371.0m $417.0m $464.0m $472.0m $619.0m $627.0m $635.0m $623.0m $732.0m
Amortization of Intangible Assets $319.0m $371.0m $417.0m $464.0m $472.0m $619.0m $627.0m $635.0m $623.0m $732.0m
Depreciation $227.0m $271.0m $306.0m $314.0m $340.0m $371.0m $371.0m $393.0m $427.0m $461.0m
Depreciation, Depletion and Amortization $752.0m $859.0m $966.0m $1.0b $1.1b $1.3b $1.3b $1.3b $1.4b $1.6b
Deferred Income Tax Expense (Benefit) ($46.0m) $36.0m ($1.6b) $126.0m $48.0m ($237.0m) $58.0m ($206.0m) ($370.0m) $392.0m
Deferred income tax (benefit) expense ($46.0m) $36.0m ($1.6b) $126.0m $48.0m ($237.0m) $58.0m ($206.0m) ($370.0m) $392.0m
Goodwill and other impairments $14.0m $16.0m $215.0m $264.0m $270.0m $36.0m $977.0m $170.0m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $216.0m $0 $456.0m
Payment, Tax Withholding, Share-based Payment Arrangement $95.0m $120.0m $136.0m $110.0m $114.0m $122.0m $155.0m $195.0m $149.0m
Share-based Payment Arrangement, Noncash Expense $97.0m $113.0m $119.0m $127.0m $142.0m $171.0m $168.0m $205.0m $229.0m $243.0m
Share-based compensation $97.0m $113.0m $119.0m $127.0m $142.0m $171.0m $168.0m $205.0m $229.0m $243.0m
Income Tax Expense (Benefit) $274.0m $1.0b ($1.2b) $479.0m $355.0m $287.0m $325.0m $508.0m $499.0m $1.3b
Interest Expense Nonoperating $607.0m
Operating Lease, Expense $133.0m $130.0m $133.0m $149.0m $172.0m $190.0m $205.0m
Changes in operating assets and liabilities:
Additional Financial Items
Accounts payable ($16.0m) $21.0m $116.0m $63.0m $100.0m $329.0m $290.0m $77.0m $192.0m $94.0m
Accounts receivable ($192.0m) ($162.0m) ($60.0m) ($563.0m) $354.0m ($377.0m) ($579.0m) ($175.0m) ($321.0m) $127.0m
Accrued expenses and other liabilities $174.0m $90.0m $289.0m $113.0m ($54.0m) $315.0m $328.0m $533.0m $74.0m $318.0m
Acquisitions, net of cash acquired ($4.3b) ($831.0m) ($2.5b) ($802.0m) ($4.2b) ($339.0m) ($2.6b) ($390.0m) ($1.6b) ($5.0b)
Goodwill $6.4b $7.2b $8.6b $9.1b $12.8b $12.9b $14.9b $15.2b $15.9b $19.3b
Income taxes ($190.0m) $704.0m ($156.0m) ($105.0m) ($16.0m) ($98.0m) ($238.0m) ($4.0m) ($116.0m) ($145.0m)
Increase (Decrease) in Accounts Receivable $192.0m $162.0m $60.0m $563.0m ($354.0m) $377.0m $579.0m $175.0m $321.0m ($127.0m)
Increase (Decrease) in Inventories $299.0m $320.0m $385.0m $400.0m ($27.0m) $189.0m $762.0m $797.0m $206.0m $297.0m
Inventories ($299.0m) ($320.0m) ($385.0m) ($400.0m) $27.0m ($189.0m) ($762.0m) ($797.0m) ($206.0m) ($297.0m)
Nonoperating Income (Expense) ($245.0m) ($227.0m) ($181.0m) ($151.0m) ($269.0m) ($303.0m) ($158.0m) ($215.0m) ($197.0m) $232.0m
Operating Expenses $5.3b $5.9b $6.4b $7.0b $6.8b $8.4b $8.7b $9.2b $10.8b $11.2b
Other, net $176.0m ($254.0m) $44.0m ($113.0m) $2.0m ($47.0m) ($107.0m) ($134.0m) ($306.0m) ($470.0m)
Proceeds (payments) on short-term borrowings, net $209.0m ($200.0m) ($1.0m) ($7.0m) ($6.0m) ($7.0m) ($375.0m) $540.0m ($32.0m) $0
Proceeds from the sale of the Spinal Implants business $0 $0 $165.0m
Sale of inventory stepped up to fair value at acquisition $36.0m $22.0m $16.0m $67.0m $48.0m $266.0m $12.0m $0 $46.0m $173.0m
Derivative, Gain (Loss) on Derivative, Net ($57.0m) $50.0m $12.0m ($13.0m) ($8.0m) $11.0m
Net Cash Provided by (Used in) Operating Activities $1.8b $1.6b $2.6b $2.2b $3.3b $3.3b $2.6b $3.7b $4.2b $5.0b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $490.0m $598.0m $572.0m $649.0m $487.0m $525.0m $588.0m $575.0m $755.0m $761.0m
Payments to Acquire Businesses, Net of Cash Acquired $4.3b $831.0m $2.5b $802.0m $4.2b $339.0m $2.6b $390.0m $1.6b $5.0b
Proceeds/(Purchases) of short-term investments $0 ($750.0m) $750.0m
Other investing, net ($3.0m) ($1.0m) ($2.0m) $1.0m $1.0m ($1.0m) $39.0m $1.0m $43.0m ($60.0m)
Payments for (Proceeds from) Other Investing Activities $3.0m $1.0m $2.0m ($1.0m) ($1.0m) $1.0m ($39.0m) ($1.0m) ($43.0m) $60.0m
Net Cash Provided by (Used in) Investing Activities ($4.2b) ($1.6b) ($2.9b) ($1.5b) ($4.7b) ($859.0m) ($2.9b) ($962.0m) ($3.0b) ($4.9b)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $3.5b $499.0m $3.1b $2.6b $3.3b $5.0m $1.5b $1.2b $3.0b $3.0b
Payments on long-term debt ($750.0m) $0 ($669.0m) ($1.3b) ($2.3b) ($1.2b) ($653.0m) ($2.1b) ($2.0b) ($1.4b)
Repayments of Long-term Debt $669.0m $1.3b $2.3b $1.2b $653.0m $2.1b $2.0b $1.4b
Payments for Repurchase of Common Stock $13.0m $230.0m $300.0m $307.0m $0 $0
Dividends Payable, Current $159.0m $178.0m $192.0m $213.0m $237.0m $263.0m $284.0m $304.0m $320.0m $337.0m
Dividends paid $568.0m $636.0m $703.0m $778.0m $863.0m $950.0m $1.1b $1.1b $1.2b $1.3b
Payments of dividends ($568) ($636) ($703) ($778) ($863) ($950) ($1k) ($1k) ($1k) ($1k)
Other financing, net ($6.0m) ($33.0m) $10.0m ($69.0m) ($27.0m) ($148.0m) ($48.0m) ($23.0m) ($51.0m) ($33.0m)
Proceeds from (Payments for) Other Financing Activities ($6.0m) ($33.0m) $10.0m ($69.0m) ($27.0m) ($148.0m) ($48.0m) ($23.0m) ($51.0m) ($33.0m)
Net Cash Provided by (Used in) Financing Activities $2.4b ($794.0m) $1.3b $3.0m ($11.0m) ($2.4b) ($749.0m) ($1.6b) ($525.0m) $113.0m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($45.0m) $74.0m ($8.0m) ($18.0m) $41.0m ($38.0m) ($51.0m) ($28.0m) ($36.0m) $68.0m
Effect of exchange rate changes on cash and cash equivalents ($45.0m) $74.0m ($8.0m) ($18.0m) $41.0m ($38.0m) ($51.0m) ($28.0m) ($36.0m) $68.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($45.0m) $74.0m ($8.0m) ($18.0m) ($1.4b) $1.0m ($1.1b) $1.1b $681.0m $359.0m
Cash and cash equivalents at beginning of year $3.4b $3.3b $2.5b $3.6b $2.9b $2.9b $1.8b $3.0b $3.7b $4.0b
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.9b $2.9b $1.8b $3.0b $3.7b $4.0b
Change in cash and cash equivalents ($63.0m) ($774.0m) $1.1b $721.0m ($1.4b) $1.0m ($1.1b) $1.1b $681.0m $359.0m
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $180.0m $264.0m $248.0m $286.0m $304.0m $325.0m $324.0m $356.0m $396.0m $582.0m
Income Taxes Paid, Net $510.0m $312.0m $539.0m $457.0m $323.0m $622.0m $505.0m $693.0m $989.0m $1.0b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.